Breaking News Instant updates and real-time market news.

TORC

ResTORbio

$8.08

-0.68 (-7.76%)

, NVS

Novartis

$80.51

-1.35 (-1.65%)

08:15
05/14/19
05/14
08:15
05/14/19
08:15

ResTORbio appoints Lloyd Klickstein as CSO

ResTORbio (TORC) announced the appointment of Lloyd Klickstein as CSO. Klickstein brings to ResTORbio a background in drug discovery and development for new clinical indications with high unmet medical need. Prior to joining resTORbio, Klickstein was the global head of translational medicine for the new indication discovery unit and the exploratory disease area at Novartis (NVS), where he led teams that brought forward multiple programs in a wide array of therapeutic areas including the research and development of small molecules for nonalcoholic steatohepatitis, gene therapy for hearing loss, gene editing for sickle cell anemia and TORC1 inhibitors for diseases of aging.

TORC

ResTORbio

$8.08

-0.68 (-7.76%)

NVS

Novartis

$80.51

-1.35 (-1.65%)

  • 14

    May

  • 23

    May

  • 31

    May

TORC ResTORbio
$8.08

-0.68 (-7.76%)

07/26/18
LEER
07/26/18
NO CHANGE
LEER
Outperform
Positive top-line data should Drive ResTORbio 'much higher,' says Leerink
Leerink analyst Geoffrey Porges notes that ResTORbio announced positive topline results from the phase IIb trial for RTB101 in elderly subjects at high risk for developing a respiratory tract infection. The analyst believes the positive top-line data should drive the shares "much higher." He reiterates an Outperform rating on the shares.
07/31/18
EVER
07/31/18
DOWNGRADE
EVER
In Line
ResTORbio downgraded to In Line from Outperform at Evercore ISI
08/01/18
08/01/18
DOWNGRADE
Target $17

In Line
ResTORbio downgraded to In Line at Evercore ISI
Analyst As previously reported, Evercore ISI downgraded ResTorbio to In Line from Outperform. Analyst Josh Schimmer is less enthusiastic following P2b results saying it has been difficult to pin down a clearly active dose to support the underlying proposed biology. Shimmer believes an investment in ResTORbio is too speculative and cut its price target to $17 from $29 to reflect equity dilution for equity raises to fund Phase 3 trials.
NVS Novartis
$80.51

-1.35 (-1.65%)

05/09/19
LEHM
05/09/19
NO CHANGE
Target $245
LEHM
Equal Weight
Barclays cuts Biogen target to $245 on reduced Spinraza estimates
Barclays analyst Geoff Meacham lowered his price target for Biogen (BIIB) to $245 from $250 citing growing uncertainty in spinal muscular atrophy. Concerns over Spinraza in spinal muscular atrophy have intensified with the impending launch of Novartis' (NVS) gene therapy Zolgensma and Roche (RHHBY)/PTC's (PTCT) oral risdiplam, Meacham tells investors in a research note. The analyst says his feedback from key opinion leaders was "direct and unequivocal," with the leaders predicting "robust uptake" of both Zolgensma and risdiplam given signs of improved efficacy. This was at the expense of Spinraza driven by the clinical burden of intrathecal injections, says Meacham. On the basis of this feedback, he lowered his longer-term Spinraza outlook by ~$150M per year. The analyst now forecasts sales of $2.0B in 2019, declining to $1.7B in 2023. He keeps an Equal Weight rating on Biogen.
05/09/19
STFL
05/09/19
NO CHANGE
STFL
Buy
Novartis deal makes Aerie 'look like a steal' at current levels, says Stifel
Stifel analyst Annabel Samimy said Novartis' (NVS) agreement to buy Takeda's (TAK) dry eye product Xiidra for $3.4B upfront in cash and up to an additional $1.9B in potential milestone payments "clearly frames the value for innovative ophthalmologic assets" and makes shares of Aerie Pharmaceuticals (AERI) "look like a steal." Applying the same peak sales multiple that Novartis paid for Xiidra implies a market-value of greater than $6B for Aerie, said Samimy, who noted that she does not expect an immediate takeout of Aerie but remains a buyer of the shares.
05/13/19
CANT
05/13/19
NO CHANGE
Target $405
CANT
Neutral
Regeneron price target lowered to $405 from $441 at Cantor Fitzgerald
Cantor Fitzgerald analyst Regeneron Pharmaceuticals (REGN) to $405 from $441 saying the company's expenses are tracking higher than his projections. Further, he thinks investor concerns about Novartis' (NVS) brolucizumab approval in eye and increased atopic dermatitis competition remain headwinds for share upside. The analyst reiterates a Neutral rating on Regeneron following its Q1 results.
05/13/19
WELS
05/13/19
NO CHANGE
WELS
Lawsuit against Teva, others to hit generic drug stocks, says Wells Fargo
Wells Fargo analyst David Maris believes the lawsuit by 44 states against 20 generic drugmakers will weigh on generic drug stocks this week and remain an "overhang issue for some time." Actual penalties and damages are impossible to calculate, but could be material, Maris tells investors in a research note. The analyst spoke to the Connecticut attorney general's office this morning and learned they are preparing for trial in these cases. Language the attorney general has used, such as "unprecedented" and his desire to clawback all gains from collusion, should be indicative of the states' intent, Maris writes. He believes that for a sector that is generally highly levered, and with some companies named already facing an overhang from opioid litigation like Teva (TEVA), this is "especially unwelcome news."

TODAY'S FREE FLY STORIES

BCRX

BioCryst

$3.54

0.09 (2.61%)

05:25
05/24/19
05/24
05:25
05/24/19
05:25
Downgrade
BioCryst rating change  »

BioCryst downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

MRBK

Meridian Bank

$16.95

(0.00%)

05:25
05/24/19
05/24
05:25
05/24/19
05:25
Earnings
Meridian reports Q1 EPS 31c, consensus 22c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$282.19

-3.43 (-1.20%)

05:24
05/24/19
05/24
05:24
05/24/19
05:24
General news
U.K. Prime Minister Theresa May announces she'll step down on June 7 »

In a public address,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$282.19

-3.43 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IONS

Ionis Pharmaceuticals

$67.13

-1.42 (-2.07%)

05:20
05/24/19
05/24
05:20
05/24/19
05:20
Recommendations
Ionis Pharmaceuticals analyst commentary  »

Piper 'incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 17

    Jun

  • 18

    Jun

ADSK

Autodesk

$169.64

-4.47 (-2.57%)

05:14
05/24/19
05/24
05:14
05/24/19
05:14
Recommendations
Autodesk analyst commentary  »

Autodesk Q1 results did…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jun

  • 12

    Jun

SPLK

Splunk

$128.68

-7.12 (-5.24%)

05:10
05/24/19
05/24
05:10
05/24/19
05:10
Recommendations
Splunk analyst commentary  »

Splunk exceeded most…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

  • 09

    Jul

AMZN

Amazon.com

$1,815.30

-42.44 (-2.28%)

05:06
05/24/19
05/24
05:06
05/24/19
05:06
Recommendations
Amazon.com analyst commentary  »

Amazon shares will rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 25

    Jun

AAXN

Axon

$67.06

-1.29 (-1.89%)

04:58
05/24/19
05/24
04:58
05/24/19
04:58
Downgrade
Axon rating change  »

Axon downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 20

    Jun

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

, ORN

Orion Group

$1.87

-0.12 (-6.03%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Hot Stocks
Kontoor Brands to replace Orion Group in S&P 600 at open on 5/24 »

V.F. Corp. (VFC) is…

KTB

Kontoor Brands

$38.51

0.82 (2.18%)

ORN

Orion Group

$1.87

-0.12 (-6.03%)

VFC

VF Corp.

$84.06

-6.32 (-6.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

04:55
05/24/19
05/24
04:55
05/24/19
04:55
General news
Breaking General news story  »

Week of 5/24 Baker-Hughes…

QGEN

Qiagen

$38.48

-0.235 (-0.61%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Qiagen participates in a conference call with JPMorgan »

Life Science &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AEL

American Equity

$28.63

-1.25 (-4.18%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
American Equity participates in a conference call with JPMorgan »

Life Insurance Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 06

    Jun

TWI

Titan International

$4.47

-0.125 (-2.72%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Titan International management to meet with SIdoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 12

    Jun

04:55
05/24/19
05/24
04:55
05/24/19
04:55
General news
Durable Goods Orders Ex-transportation to be reported at 08:30 »

April Durable Goods…

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Deutsche Bank to hold a conference »

10th Annual Asia…

ARWR

Arrowhead

$22.08

0.28 (1.28%)

, NAVG

Navigators

$69.97

(0.00%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Hot Stocks
Arrowhead to replace Navigators in S&P 600 at open on 5/24 »

The Hartford Financial…

ARWR

Arrowhead

$22.08

0.28 (1.28%)

NAVG

Navigators

$69.97

(0.00%)

HIG

Hartford Financial

$53.31

-0.915 (-1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ANTM

Anthem

$277.80

-5.16 (-1.82%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Anthem participates in a conference call with JPMorgan »

Managed Care/Facilities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 29

    May

ABB

ABB

$18.70

-0.26 (-1.37%)

, ALV

Autoliv

$64.53

-0.225 (-0.35%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Jefferies to hold a tour »

5th Annual European…

ABB

ABB

$18.70

-0.26 (-1.37%)

ALV

Autoliv

$64.53

-0.225 (-0.35%)

ASAZY

Assa Abloy

$0.00

(0.00%)

ATLKY

Atlas Copco

$0.00

(0.00%)

EPOKY

Epiroc

$0.00

(0.00%)

SDVKY

Sandvik AB

$0.00

(0.00%)

VLVLY

Volvo AB

$0.00

(0.00%)

VNE

Veoneer

$17.45

-0.5 (-2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 23

    May

HPR

HighPoint Resources

$2.03

-0.16 (-7.31%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
HighPoint Resources management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

04:55
05/24/19
05/24
04:55
05/24/19
04:55
General news
Durable Goods Orders to be reported at 08:30 »

April Durable Goods…

NGD

New Gold

$0.64

-0.0022 (-0.34%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
New Gold management to meet with TD Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

BLCM

Bellicum Pharmaceuticals

$2.31

-0.18 (-7.23%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Bellicum Pharmaceuticals management to meet with Ladenburg »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 13

    Jun

INFY

Infosys

$10.16

-0.06 (-0.59%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Infosys management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SSNLF

Samsung

$0.00

(0.00%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
CLSA to hold a forum »

15th Annual CLSA Japan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTD

Mettler-Toledo

$718.92

-5.53 (-0.76%)

04:55
05/24/19
05/24
04:55
05/24/19
04:55
Conference/Events
Mettler-Toledo participates in a conference call with JPMorgan »

Science & Diagnostic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.